Bullous pemphigoid treated with leflunomide: a novel immunomodulatory agent.
Nousari
H C
HC
Division of Dermatoimmunology, Johns Hopkins Medical Institutions, 720 Rutland Ave, Room 771, Baltimore, MD 21205, USA. hnousar@jhmi.edu
Anhalt
G J
GJ
D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D008297:Male; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000188:drug therapy*; D019233:Retreatment
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide